Bellander Bo-Michael, Cantais Emmanuel, Enblad Per, Hutchinson Peter, Nordström Carl-Henrik, Robertson Claudia, Sahuquillo Juan, Smith Martin, Stocchetti Nino, Ungerstedt Urban, Unterberg Andreas, Olsen Niels Vidiendal
Section of Neurosurgery, Department of Clinical Neuroscience, Karolinska Institutet and Hospital, Stockholm, Sweden.
Intensive Care Med. 2004 Dec;30(12):2166-9. doi: 10.1007/s00134-004-2461-8. Epub 2004 Nov 10.
Microdialysis is used in many European neurointensive care units to monitor brain chemistry in patients suffering subarachnoid hemorrhage (SAH) or traumatic brain injury (TBI).
We present a consensus agreement achieved at a meeting in Stockholm by a group of experienced users of microdialysis in neurointensive care, defining the use of microdialysis, placement of catheters, unreliable values, chemical markers, and clinical use in SAH and in TBI.
As microdialysis is maturing into a clinically useful technique for early detection of cerebral ischemia and secondary brain damage, there is a need to following such definition regarding when and how to use microdialysis after SAH and TBI.
在许多欧洲神经重症监护病房中,微透析用于监测蛛网膜下腔出血(SAH)或创伤性脑损伤(TBI)患者的脑化学物质。
我们展示了一组神经重症监护中微透析经验丰富的使用者在斯德哥尔摩会议上达成的共识,定义了微透析的使用、导管放置、不可靠值、化学标志物以及在SAH和TBI中的临床应用。
随着微透析逐渐发展成为一种用于早期检测脑缺血和继发性脑损伤的临床有用技术,有必要遵循关于SAH和TBI后何时以及如何使用微透析的此类定义。